---
schema_version: "secwatch.filing_event.v1"
accession: "0001801170-22-000006"
form_type: "8-K"
ticker: "CLOV"
cik: "0001801170"
company_name: "CLOVER HEALTH INVESTMENTS, CORP. /DE"
filed_at: "2022-01-19T23:59:59+00:00"
generated_at: "2026-06-27T17:15:53.969714+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# Clover Health General Counsel Gia Lee steps down; Karen Soares named Interim GC

## Summary
- Gia Lee, General Counsel, steps down effective Jan 19, 2022; Karen Soares named Interim General Counsel.
- Lee receives separation payments: $520k (12 months base salary + prior year bonus), $120k (2021 bonus), $700k special cash bonus for de-SPAC work.
- During 12-month consulting period, Lee gets $10k/month and continued stock option vesting; she may terminate consulting at any time.
- Departure not due to any disagreement; CEO Vivek Garipalli thanked Lee for her contributions.

## SEC filing metadata
- accession: 0001801170-22-000006
- form_type: 8-K
- ticker: CLOV
- cik: 0001801170
- company_name: CLOVER HEALTH INVESTMENTS, CORP. /DE
- filed_at: 2022-01-19T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1801170/000180117022000006/0001801170-22-000006-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1801170/000180117022000006/clov-20220113.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001801170-22-000006
- JSON: https://secwatch.observer/filing/0001801170-22-000006.json
- Plain text: https://secwatch.observer/filing/0001801170-22-000006.txt

## Key facts
- Executive change
  Gia Lee departed as General Counsel at CLOVER HEALTH INVESTMENTS, CORP. /DE.
  - Action: stepping down
  - Role: General Counsel
  source text: Gia Lee, the Company’s General Counsel, will be stepping down as an officer of the Company today.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1801170/000180117022000006/0001801170-22-000006-index.htm
- Executive change
  Karen Soares was appointed as Interim General Counsel at CLOVER HEALTH INVESTMENTS, CORP. /DE.
  - Action: appointed
  - Role: Interim General Counsel
  source text: Effective on January 19, 2022, and until a permanent replacement for Ms. Lee has been named, Karen Soares, the Company’s Deputy General Counsel, will serve as the Company’s Interim General Counsel.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1801170/000180117022000006/0001801170-22-000006-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.